KTTA
Pasithea Therapeutics
$0.37
−$0.02 (−5.85%)Oct 29, 2026
Key metrics
The numbers that frame KTTA today
- Market cap
- $12.36M
- ROIC
- 3,511.6%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $0.28
- 52wk High
- $2.06
Growth
Revenue and earnings trend for KTTA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KTTA
Is Pasithea Therapeutics a good buy?
No. Pasithea Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case.
What is the market capitalization of KTTA?
Pasithea Therapeutics's market capitalization is $12.36M.
What is the 52-week high for KTTA stock?
The 52-week high for Pasithea Therapeutics is $2.06. The current close of $0.37 is 82% below that high.
What is the 52-week low for KTTA stock?
The 52-week low for Pasithea Therapeutics is $0.28. The current close of $0.37 is 31.7% above that low.
Does KTTA stock pay dividends?
Pasithea Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KTTA?
Pasithea Therapeutics's Debt / Equity ratio is 0.